Department of Human and Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
Hepatology. 2013 Jan;57(1):228-38. doi: 10.1002/hep.25983.
Negative feedback immune mechanisms are essential for maintenance of hepatic homeostasis and prevention of immune-mediated liver injury. We show here that scavenger receptor A (SRA/CD204), a pattern recognition molecule, is highly up-regulated in the livers of patients with autoimmune or viral hepatitis, and of mice during concanavalin A (Con A)-induced hepatitis (CIH). Strikingly, genetic SRA ablation strongly sensitizes mice to Con A-induced liver injury. SRA loss, increased mortality and liver pathology correlate with excessive production of IFN-γ and heightened activation of T cells. Increased liver expression of SRA primarily occurs in mobilized hepatic myeloid cells during CIH, including CD11b(+) Gr-1(+) cells. Mechanistic studies establish that SRA on these cells functions as a negative regulator limiting T-cell activity and cytokine production. SRA-mediated protection from CIH is further validated by adoptive transfer of SRA(+) hepatic mononuclear cells or administration of a lentivirus-expressing SRA, which effectively ameliorates Con A-induced hepatic injury. Also, CIH and clinical hepatitis are associated with increased levels of soluble SRA. This soluble SRA displays a direct T-cell inhibitory effect and is capable of mitigating Con A-induced liver pathology.
Our findings demonstrate an unexpected role of SRA in attenuation of Con A-induced, T-cell-mediated hepatic injury. We propose that SRA serves as an important negative feedback mechanism in liver immune homeostasis, and may be exploited for therapeutic treatment of inflammatory liver diseases.
负反馈免疫机制对于维持肝脏内稳态和防止免疫介导的肝损伤至关重要。我们在此表明,清道夫受体 A(SRA/CD204)是一种模式识别分子,在自身免疫性或病毒性肝炎患者的肝脏中以及在用伴刀豆球蛋白 A(Con A)诱导的肝炎(CIH)的小鼠中高度上调。引人注目的是,遗传 SRA 缺失使小鼠对 Con A 诱导的肝损伤更加敏感。SRA 缺失、死亡率增加和肝病理学与 IFN-γ的过度产生和 T 细胞的高度激活相关。CIH 期间,SRA 在动员的肝髓样细胞中(包括 CD11b(+)Gr-1(+)细胞)主要在肝脏中表达增加。机制研究确立了这些细胞上的 SRA 作为负调节剂,限制 T 细胞活性和细胞因子产生。通过 SRA(+)肝单核细胞的过继转移或表达 SRA 的慢病毒的给药来验证 SRA 介导的对 CIH 的保护,这有效地改善了 Con A 诱导的肝损伤。此外,CIH 和临床肝炎与可溶性 SRA 水平升高相关。这种可溶性 SRA 显示出直接的 T 细胞抑制作用,并能够减轻 Con A 诱导的肝病理。
我们的发现表明 SRA 在减弱 Con A 诱导的 T 细胞介导的肝损伤中具有意想不到的作用。我们提出 SRA 作为肝脏免疫内稳态的重要负反馈机制,可用于治疗炎症性肝病。